Actin-Binding TB-500: How It Supports Healing and Recovery
Actin-binding peptides like TB-500 have gained attention in peptide research for their influence on healing and recovery. At Oath Research, we’ve observed growing interest in these compounds due to their applications in soft-tissue regeneration, angiogenesis, and cellular function. This article examines what makes actin-binding TB-500 a valuable tool for research teams studying recovery mechanisms and healing processes.
Updated on March 4, 2026 — references verified, newer research added.
—
The Role of Actin-Binding in Cellular Health
Actin is a fundamental protein present in nearly all eukaryotic cells. It provides scaffolding and drives essential processes, such as cell division, locomotion, and the transport of various substances within the cell. The actin cytoskeleton’s versatility allows for constant shape-shifting—crucial in healing and repair mechanisms across tissues.
Actin-binding peptides like TB-500 work by interacting directly with actin filaments, enabling dynamic changes that promote cellular mobilization and tissue repair. By targeting actin, researchers can study mechanisms that potentially accelerate both the restoration of injured tissue and overall recovery time.
Mechanism of Action: TB-500 and Actin-Binding
TB-500 is a synthetic research peptide modeled after a naturally occurring region of thymosin beta-4 (Tβ4), a protein implicated in wound healing and inflammatory response. Its primary characteristic is its ability to bind globular (G) actin, resulting in mobilization of cells such as fibroblasts, endothelial cells, and progenitor cells.
Early research characterized Tβ4’s actin interaction primarily as G-actin sequestration—preventing free actin from polymerizing. A 2024 study in BMC Biology (PMID 39443925) has refined this model: Tβ4 binding to G-actin can also facilitate actin polymerization during regenerative contexts such as axon regrowth, suggesting the peptide plays a more dynamic scaffolding role than previously understood. The canonical angiogenic mechanism—driven by a seven-amino-acid actin-binding motif—was established in foundational work by Philp et al. (2003, PMID 14500546) published in the FASEB Journal.
These processes can enhance soft-tissue healing by promoting:
– Cell migration, which helps close wounds faster – Reduced fibrosis and scar tissue formation — Tβ4 and its N-terminal peptide Ac-SDKP prevent fibroblast-to-myofibroblast conversion and promote aligned collagen deposition (Kleinman et al., 2023, PMID 36580759) – Facilitation of angiogenesis, the creation of new blood vessels that improve nutrient delivery and waste removal
In laboratory settings, actin-binding by TB-500 provides a model for studying how cellular resources reallocate toward repair and regeneration.
—
Angiogenesis: Why New Blood Vessels Matter
One of the notable benefits observed in research of actin-binding TB-500 is its effect on angiogenesis. Angiogenesis is the formation of new blood vessels—a process vital for nourishing healing tissue. Inadequate blood flow after injury stalls the healing process, whereas robust vascularization ensures a constant supply of oxygen, nutrients, and reparative cells.
The seven-amino-acid actin-binding motif of Tβ4 is essential for angiogenic activity. Philp et al. (2003) demonstrated that this motif promotes endothelial cell migration and vessel sprouting at concentrations as low as 50 nM, and that soluble actin inhibits the response—confirming that actin-binding is mechanistically required for the angiogenic effect (PMID 14500546).
Actin-binding peptides in experimental settings have shown potential in:
– Enhancing wound closure rates in models where normal angiogenic activity is deficient – Supporting regeneration in soft tissues, including muscle and tendon – Potentially improving outcomes in chronic wounds, such as those associated with diabetes or compromised vascular supply
For research teams, exploring angiogenesis with actin-binding TB-500 opens a pathway toward understanding soft-tissue regeneration on a cellular level—a key area for developing innovative therapies and interventions.
—
Soft-Tissue Healing and the Regenerative Potential of TB-500
Soft-tissue injuries, whether muscle strains or tendon tears, present unique challenges because they often lack an abundant blood supply. This impairs the removal of metabolic waste and slows down the delivery of reparative cells. This is where actin-binding TB-500 research proves valuable.
Soft-Tissue Recovery and Regeneration
Research demonstrates that TB-500, through its actin-binding capabilities, may:
– Accelerate the migration of repair cells (fibroblasts and progenitors) to the injury site – Increase keratinocyte and endothelial cell function, relevant to both surface and underlying tissue repair – Modulate inflammatory responses, helping to shift from a pro-inflammatory to a pro-healing profile
A 2024 study in the Journal of Chromatography B (PMID 38382158) conducted the first systematic profiling of TB-500 metabolites in biological systems, finding that the metabolite Ac-LKKTE demonstrated significantly increased wound healing activity in fibroblast scratch assays compared to controls, with no cytotoxicity observed. This provides 2024 preclinical data directly supporting the peptide’s wound-healing activity at the metabolite level.
Such properties make TB-500 a valuable tool for research teams investigating soft-tissue healing and regeneration. To view our selection of peptides relevant to this topic, explore our healing and recovery peptides for research use only.
—
TB-500 in Research: Healing and Recovery Benchmarks
Oath Research has tracked how advancements with actin-binding TB-500 have impacted the scientific community’s ability to investigate and optimize recovery. Below are some key findings:
– Inflammation Reduction: Laboratory work reveals that actin-binding peptides may help reduce harmful local and systemic inflammation at the injury site, creating conditions more conducive to healing. – Increase in Stem Cell Mobilization: TB-500’s presence in experimental studies enhances the number of mesenchymal stem cells in targeted areas, potentially facilitating tissue repair and regeneration. – Thrombus and Scar Mitigation: Research has shown that Tβ4 and its peptide fragment Ac-SDKP prevent fibrosis across multiple organ systems by reducing macrophage infiltration, decreasing TGF-β and IL-10 levels, and preventing fibroblast-to-myofibroblast conversion (Kleinman et al., Int Immunopharmacol, 2023; PMID 36580759).
Every peptide available at Oath Research is strictly intended for research purposes and must not be used in research subjects including humans or animals.
—
Actin-Binding, Angiogenesis, and Regenerative Medicine
The connection between actin-binding, angiogenesis, and regenerative medicine is a primary focus at OathPeptides.com. Actin-binding peptides allow research scientists to evaluate cell migration, wound healing kinetics, and tissue regeneration in controlled experimental settings.
Cellular Dynamics and the Healing Cascade
Studying the actin cytoskeleton’s response to TB-500 in real time reveals important cellular processes:
1. Rapid recruitment of progenitor cells to the wound site 2. Formation of temporary scaffolds enabling organized cellular infiltration and matrix deposition 3. Promotion of angiogenic sprouting for nutrient and oxygen replenishment 4. Transition from inflammation to healing, orchestrated by localized cellular signals
Understanding this cascade is crucial for those researching healing and regeneration, including those focused on sports injuries, post-operative recovery, and degenerative tissue conditions.
—
Exploring Regeneration Beyond Muscle and Tendon
While much of the TB-500 literature focuses on muscle and tendon recovery, actin-binding mechanisms are emerging as potential areas of interest in other tissues:
– Myocardial (Heart) Tissue: Early-stage research examines how actin-binding may contribute to heart tissue repair after ischemic injury (such as heart attacks) by stimulating angiogenesis and cellular renewal. Studies in mesenchymal stem cell models have shown Tβ4 expression supports cardiomyocyte repair in ischemic settings (PMID 24030419). – Neurological Tissue: The ability of Tβ4 to bind G-actin and promote actin polymerization is directly relevant to axon regeneration. A 2024 study in BMC Biology found that Tβ4 knockout impaired axon regrowth in zebrafish, while overexpression promoted Mauthner axon regeneration and restored rapid escape behavior—functional neurological recovery (PMID 39443925). A 2025 study in Stem Cell Reports expanded this further, identifying Tβ4 as a potential Alzheimer’s disease intervention target: Tβ4 treatment in iPSC-derived human brain organoids restored neuronal development, reduced amyloid-beta production, and protected against apoptosis, while gene therapy delivering TMSB4X decreased amyloid plaques and neuroinflammation in 5xFAD transgenic mice (PMID 40816274). – Skin and Epithelial Tissues: Studies have shown outcomes in accelerated wound closure, decreased scar formation, and improved functional recovery of skin damage.
The Molecular Structure of TB-500: Why Actin-Binding Matters
TB-500’s structure is based on a specific sequence that enables high-affinity binding to globular (G) actin, one of the two common forms of actin present in cells. Recent mechanistic work demonstrates that this binding does not simply sequester G-actin to prevent polymerization—it can also facilitate the transition to filamentous (F) actin during active regenerative processes, depending on cellular context (PMID 39443925). This dynamic role helps researchers study:
– The stabilization and mobilization of actin filaments – How actin-binding affects cellular movement and shape – Mechanisms by which cellular matrix and vascular structures are remodeled during healing
This molecular flexibility makes TB-500 a valuable resource for cell biology and regenerative medicine experiments.
—
Actin-Binding Peptide TB-500: A Researcher’s Toolkit
To further highlight how actin-binding TB-500 is utilized in modern laboratories, let’s examine some typical research contexts:
Wound Healing Assays
Researchers regularly assess the effect of TB-500 on wound closure by measuring the rate at which cell monolayers close a scratch or gap in vitro. Accelerated closure in the presence of actin-binding agents points to increased cellular migration, a hallmark of efficient repair. The 2024 metabolite profiling study (PMID 38382158) used precisely this approach, finding TB-500’s metabolite Ac-LKKTE outperformed the parent peptide in fibroblast scratch assays.
Angiogenesis Assessments
Specialized assays, like the tube formation assay, allow scientists to observe the formation of capillary-like structures under TB-500 exposure. Enhanced angiogenesis correlates with improved healing outcomes in soft-tissue injuries.
Soft-Tissue Regeneration Studies
These encompass everything from tendon and ligament repair models to investigations into recovery after muscle trauma. Outcomes are measured by looking at tissue strength, elasticity, and overall integrity after experimental intervention with TB-500. A 2026 peer-reviewed review in the Journal of the American Academy of Orthopaedic Surgeons Global Research & Reviews confirmed TB-500’s mechanisms of actin polymerization promotion and progenitor cell recruitment, while noting the current absence of human clinical trials as a key limitation for the field (PMID 41490200).
Safety and Compliance: Responsible Research Practices at Oath Research
At Oath Research, we emphasize care and accountability in peptide research. It’s essential to remember that all peptides from our store—including actin-binding TB-500—are strictly for laboratory research use only. Any use in research subjects including humans or animals is expressly prohibited and outside the intended purpose.
Regulatory Note: TB-500 (thymosin beta-4) is included on the World Anti-Doping Agency (WADA) Prohibited List under Section S2 (Peptide Hormones, Growth Factors, Related Substances, and Mimetics). It is banned in-competition and out-of-competition for all sports. All products offered by Oath Research are strictly for in-vitro and preclinical laboratory research use only and are not intended for any sporting or athletic application.
All OathPeptides.com customers are required to confirm compliance with our research-use terms, helping maintain high standards in scientific practice.
—
Related Peptides & Further Investigation
If your research extends beyond actin-binding, you may also be interested in exploring other peptide categories:
As always, every product is strictly not for human or animal consumption and is to be used exclusively in regulated laboratory environments.
—
Choosing OathPeptides.com for Your Research
OathPeptides.com is committed to helping both established and emerging research teams advance the boundaries of healing, recovery, and regeneration science. Our commitment to purity, transparency, and compliance makes us a trusted partner for academic, corporate, and independent research labs.
Browse our full catalog of research peptides to discover our selection of actin-binding TB-500 and related compounds for angiogenesis investigations and soft-tissue studies.
To explore TB-500 or other peptides for your research, contact our team for more information. Remember, every purchase is strictly for research use—not for human or animal administration.
—
References & Further Reading
1. Philp, D., et al. (2003). The actin binding site on thymosin beta4 promotes angiogenesis. FASEB Journal, 17(14), 2103–2105. PMID: 14500546
2. Kleinman, H.K., Kulik, G., & Goldstein, A.L. (2023). Thymosin β4 and the anti-fibrotic switch. International Immunopharmacology, 116, 109799. PMID: 36580759
3. Dai, Y., et al. (2024). Simultaneous quantification of TB-500 and its metabolites in in-vitro experiments and rats by UHPLC-Q-Exactive orbitrap MS/MS and their screening by wound healing activities in-vitro. Journal of Chromatography B, 1237, 124093. PMID: 38382158
4. Chen, X., et al. (2024). Thymosin β4 promotes zebrafish Mauthner axon regeneration by facilitating actin polymerization through binding to G-actin. BMC Biology, 22(1), 243. PMID: 39443925
5. He, Z., et al. (2025). Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids. Stem Cell Reports. PMID: 40816274
6. Sinha, S., et al. (2026). Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. J Am Acad Orthop Surg Glob Res Rev. PMID: 41490200
Always verify that all peptide usage stays strictly within legal and ethical boundaries. Oath Research’s products are not for human or animal use—laboratory testing only.
Curious if the Tesamorelin peptide burns fat? Its power lies in a unique gh-releasing action that stimulates your body’s own systems to target and reduce stubborn fat stores.
Experience stunning focus and effortless cognition with Semax peptide, a nootropic celebrated for boosting BDNF, enhancing mood, and providing neuroprotection so you can think sharper and feel better every day. Whether you’re aiming for productivity or brain health, discover how this innovative compound can help you reach your mental peak.
Actin-Binding TB-500: Healing & Recovery
Actin-Binding TB-500: How It Supports Healing and Recovery
Actin-binding peptides like TB-500 have gained attention in peptide research for their influence on healing and recovery. At Oath Research, we’ve observed growing interest in these compounds due to their applications in soft-tissue regeneration, angiogenesis, and cellular function. This article examines what makes actin-binding TB-500 a valuable tool for research teams studying recovery mechanisms and healing processes.
Updated on March 4, 2026 — references verified, newer research added.
—
The Role of Actin-Binding in Cellular Health
Actin is a fundamental protein present in nearly all eukaryotic cells. It provides scaffolding and drives essential processes, such as cell division, locomotion, and the transport of various substances within the cell. The actin cytoskeleton’s versatility allows for constant shape-shifting—crucial in healing and repair mechanisms across tissues.
Actin-binding peptides like TB-500 work by interacting directly with actin filaments, enabling dynamic changes that promote cellular mobilization and tissue repair. By targeting actin, researchers can study mechanisms that potentially accelerate both the restoration of injured tissue and overall recovery time.
Mechanism of Action: TB-500 and Actin-Binding
TB-500 is a synthetic research peptide modeled after a naturally occurring region of thymosin beta-4 (Tβ4), a protein implicated in wound healing and inflammatory response. Its primary characteristic is its ability to bind globular (G) actin, resulting in mobilization of cells such as fibroblasts, endothelial cells, and progenitor cells.
Early research characterized Tβ4’s actin interaction primarily as G-actin sequestration—preventing free actin from polymerizing. A 2024 study in BMC Biology (PMID 39443925) has refined this model: Tβ4 binding to G-actin can also facilitate actin polymerization during regenerative contexts such as axon regrowth, suggesting the peptide plays a more dynamic scaffolding role than previously understood. The canonical angiogenic mechanism—driven by a seven-amino-acid actin-binding motif—was established in foundational work by Philp et al. (2003, PMID 14500546) published in the FASEB Journal.
These processes can enhance soft-tissue healing by promoting:
– Cell migration, which helps close wounds faster
– Reduced fibrosis and scar tissue formation — Tβ4 and its N-terminal peptide Ac-SDKP prevent fibroblast-to-myofibroblast conversion and promote aligned collagen deposition (Kleinman et al., 2023, PMID 36580759)
– Facilitation of angiogenesis, the creation of new blood vessels that improve nutrient delivery and waste removal
In laboratory settings, actin-binding by TB-500 provides a model for studying how cellular resources reallocate toward repair and regeneration.
—
Angiogenesis: Why New Blood Vessels Matter
One of the notable benefits observed in research of actin-binding TB-500 is its effect on angiogenesis. Angiogenesis is the formation of new blood vessels—a process vital for nourishing healing tissue. Inadequate blood flow after injury stalls the healing process, whereas robust vascularization ensures a constant supply of oxygen, nutrients, and reparative cells.
The seven-amino-acid actin-binding motif of Tβ4 is essential for angiogenic activity. Philp et al. (2003) demonstrated that this motif promotes endothelial cell migration and vessel sprouting at concentrations as low as 50 nM, and that soluble actin inhibits the response—confirming that actin-binding is mechanistically required for the angiogenic effect (PMID 14500546).
Actin-binding peptides in experimental settings have shown potential in:
– Enhancing wound closure rates in models where normal angiogenic activity is deficient
– Supporting regeneration in soft tissues, including muscle and tendon
– Potentially improving outcomes in chronic wounds, such as those associated with diabetes or compromised vascular supply
For research teams, exploring angiogenesis with actin-binding TB-500 opens a pathway toward understanding soft-tissue regeneration on a cellular level—a key area for developing innovative therapies and interventions.
—
Soft-Tissue Healing and the Regenerative Potential of TB-500
Soft-tissue injuries, whether muscle strains or tendon tears, present unique challenges because they often lack an abundant blood supply. This impairs the removal of metabolic waste and slows down the delivery of reparative cells. This is where actin-binding TB-500 research proves valuable.
Soft-Tissue Recovery and Regeneration
Research demonstrates that TB-500, through its actin-binding capabilities, may:
– Accelerate the migration of repair cells (fibroblasts and progenitors) to the injury site
– Increase keratinocyte and endothelial cell function, relevant to both surface and underlying tissue repair
– Modulate inflammatory responses, helping to shift from a pro-inflammatory to a pro-healing profile
A 2024 study in the Journal of Chromatography B (PMID 38382158) conducted the first systematic profiling of TB-500 metabolites in biological systems, finding that the metabolite Ac-LKKTE demonstrated significantly increased wound healing activity in fibroblast scratch assays compared to controls, with no cytotoxicity observed. This provides 2024 preclinical data directly supporting the peptide’s wound-healing activity at the metabolite level.
Such properties make TB-500 a valuable tool for research teams investigating soft-tissue healing and regeneration. To view our selection of peptides relevant to this topic, explore our healing and recovery peptides for research use only.
—
TB-500 in Research: Healing and Recovery Benchmarks
Oath Research has tracked how advancements with actin-binding TB-500 have impacted the scientific community’s ability to investigate and optimize recovery. Below are some key findings:
– Inflammation Reduction: Laboratory work reveals that actin-binding peptides may help reduce harmful local and systemic inflammation at the injury site, creating conditions more conducive to healing.
– Increase in Stem Cell Mobilization: TB-500’s presence in experimental studies enhances the number of mesenchymal stem cells in targeted areas, potentially facilitating tissue repair and regeneration.
– Thrombus and Scar Mitigation: Research has shown that Tβ4 and its peptide fragment Ac-SDKP prevent fibrosis across multiple organ systems by reducing macrophage infiltration, decreasing TGF-β and IL-10 levels, and preventing fibroblast-to-myofibroblast conversion (Kleinman et al., Int Immunopharmacol, 2023; PMID 36580759).
Every peptide available at Oath Research is strictly intended for research purposes and must not be used in research subjects including humans or animals.
—
Actin-Binding, Angiogenesis, and Regenerative Medicine
The connection between actin-binding, angiogenesis, and regenerative medicine is a primary focus at OathPeptides.com. Actin-binding peptides allow research scientists to evaluate cell migration, wound healing kinetics, and tissue regeneration in controlled experimental settings.
Cellular Dynamics and the Healing Cascade
Studying the actin cytoskeleton’s response to TB-500 in real time reveals important cellular processes:
1. Rapid recruitment of progenitor cells to the wound site
2. Formation of temporary scaffolds enabling organized cellular infiltration and matrix deposition
3. Promotion of angiogenic sprouting for nutrient and oxygen replenishment
4. Transition from inflammation to healing, orchestrated by localized cellular signals
Understanding this cascade is crucial for those researching healing and regeneration, including those focused on sports injuries, post-operative recovery, and degenerative tissue conditions.
—
Exploring Regeneration Beyond Muscle and Tendon
While much of the TB-500 literature focuses on muscle and tendon recovery, actin-binding mechanisms are emerging as potential areas of interest in other tissues:
– Myocardial (Heart) Tissue: Early-stage research examines how actin-binding may contribute to heart tissue repair after ischemic injury (such as heart attacks) by stimulating angiogenesis and cellular renewal. Studies in mesenchymal stem cell models have shown Tβ4 expression supports cardiomyocyte repair in ischemic settings (PMID 24030419).
– Neurological Tissue: The ability of Tβ4 to bind G-actin and promote actin polymerization is directly relevant to axon regeneration. A 2024 study in BMC Biology found that Tβ4 knockout impaired axon regrowth in zebrafish, while overexpression promoted Mauthner axon regeneration and restored rapid escape behavior—functional neurological recovery (PMID 39443925). A 2025 study in Stem Cell Reports expanded this further, identifying Tβ4 as a potential Alzheimer’s disease intervention target: Tβ4 treatment in iPSC-derived human brain organoids restored neuronal development, reduced amyloid-beta production, and protected against apoptosis, while gene therapy delivering TMSB4X decreased amyloid plaques and neuroinflammation in 5xFAD transgenic mice (PMID 40816274).
– Skin and Epithelial Tissues: Studies have shown outcomes in accelerated wound closure, decreased scar formation, and improved functional recovery of skin damage.
For those with a focus on cellular protection and neuroprotection, browse our cellular protection peptides and neuroprotection peptides, all research-use only.
—
The Molecular Structure of TB-500: Why Actin-Binding Matters
TB-500’s structure is based on a specific sequence that enables high-affinity binding to globular (G) actin, one of the two common forms of actin present in cells. Recent mechanistic work demonstrates that this binding does not simply sequester G-actin to prevent polymerization—it can also facilitate the transition to filamentous (F) actin during active regenerative processes, depending on cellular context (PMID 39443925). This dynamic role helps researchers study:
– The stabilization and mobilization of actin filaments
– How actin-binding affects cellular movement and shape
– Mechanisms by which cellular matrix and vascular structures are remodeled during healing
This molecular flexibility makes TB-500 a valuable resource for cell biology and regenerative medicine experiments.
—
Actin-Binding Peptide TB-500: A Researcher’s Toolkit
To further highlight how actin-binding TB-500 is utilized in modern laboratories, let’s examine some typical research contexts:
Wound Healing Assays
Researchers regularly assess the effect of TB-500 on wound closure by measuring the rate at which cell monolayers close a scratch or gap in vitro. Accelerated closure in the presence of actin-binding agents points to increased cellular migration, a hallmark of efficient repair. The 2024 metabolite profiling study (PMID 38382158) used precisely this approach, finding TB-500’s metabolite Ac-LKKTE outperformed the parent peptide in fibroblast scratch assays.
Angiogenesis Assessments
Specialized assays, like the tube formation assay, allow scientists to observe the formation of capillary-like structures under TB-500 exposure. Enhanced angiogenesis correlates with improved healing outcomes in soft-tissue injuries.
Soft-Tissue Regeneration Studies
These encompass everything from tendon and ligament repair models to investigations into recovery after muscle trauma. Outcomes are measured by looking at tissue strength, elasticity, and overall integrity after experimental intervention with TB-500. A 2026 peer-reviewed review in the Journal of the American Academy of Orthopaedic Surgeons Global Research & Reviews confirmed TB-500’s mechanisms of actin polymerization promotion and progenitor cell recruitment, while noting the current absence of human clinical trials as a key limitation for the field (PMID 41490200).
For a closer look at peptides driving innovation in soft-tissue repair, visit our tissue repair peptide collection.
—
Safety and Compliance: Responsible Research Practices at Oath Research
At Oath Research, we emphasize care and accountability in peptide research. It’s essential to remember that all peptides from our store—including actin-binding TB-500—are strictly for laboratory research use only. Any use in research subjects including humans or animals is expressly prohibited and outside the intended purpose.
Regulatory Note: TB-500 (thymosin beta-4) is included on the World Anti-Doping Agency (WADA) Prohibited List under Section S2 (Peptide Hormones, Growth Factors, Related Substances, and Mimetics). It is banned in-competition and out-of-competition for all sports. All products offered by Oath Research are strictly for in-vitro and preclinical laboratory research use only and are not intended for any sporting or athletic application.
All OathPeptides.com customers are required to confirm compliance with our research-use terms, helping maintain high standards in scientific practice.
—
Related Peptides & Further Investigation
If your research extends beyond actin-binding, you may also be interested in exploring other peptide categories:
– Anti-aging peptides
– Anti-inflammatory peptides
– Performance enhancement peptides
– Longevity peptides
As always, every product is strictly not for human or animal consumption and is to be used exclusively in regulated laboratory environments.
—
Choosing OathPeptides.com for Your Research
OathPeptides.com is committed to helping both established and emerging research teams advance the boundaries of healing, recovery, and regeneration science. Our commitment to purity, transparency, and compliance makes us a trusted partner for academic, corporate, and independent research labs.
Browse our full catalog of research peptides to discover our selection of actin-binding TB-500 and related compounds for angiogenesis investigations and soft-tissue studies.
To explore TB-500 or other peptides for your research, contact our team for more information. Remember, every purchase is strictly for research use—not for human or animal administration.
—
References & Further Reading
1. Philp, D., et al. (2003). The actin binding site on thymosin beta4 promotes angiogenesis. FASEB Journal, 17(14), 2103–2105. PMID: 14500546
2. Kleinman, H.K., Kulik, G., & Goldstein, A.L. (2023). Thymosin β4 and the anti-fibrotic switch. International Immunopharmacology, 116, 109799. PMID: 36580759
3. Dai, Y., et al. (2024). Simultaneous quantification of TB-500 and its metabolites in in-vitro experiments and rats by UHPLC-Q-Exactive orbitrap MS/MS and their screening by wound healing activities in-vitro. Journal of Chromatography B, 1237, 124093. PMID: 38382158
4. Chen, X., et al. (2024). Thymosin β4 promotes zebrafish Mauthner axon regeneration by facilitating actin polymerization through binding to G-actin. BMC Biology, 22(1), 243. PMID: 39443925
5. He, Z., et al. (2025). Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids. Stem Cell Reports. PMID: 40816274
6. Sinha, S., et al. (2026). Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. J Am Acad Orthop Surg Glob Res Rev. PMID: 41490200
For more information on the responsible use of actin-binding peptides in research, visit OathPeptides.com’s compliance and resources page.
Always verify that all peptide usage stays strictly within legal and ethical boundaries. Oath Research’s products are not for human or animal use—laboratory testing only.
Related Posts
Tesamorelin peptide: Does Tesamorelin peptide burn fat?
Curious if the Tesamorelin peptide burns fat? Its power lies in a unique gh-releasing action that stimulates your body’s own systems to target and reduce stubborn fat stores.
Semax Peptide Nootropic: Stunning Focus & Effortless Cognition
Experience stunning focus and effortless cognition with Semax peptide, a nootropic celebrated for boosting BDNF, enhancing mood, and providing neuroprotection so you can think sharper and feel better every day. Whether you’re aiming for productivity or brain health, discover how this innovative compound can help you reach your mental peak.